Sisomicin

Sisomycin is an amino cyclitol glycoside, an aminoglycoside antibiotic, a beta-L-arabinoside and a monosaccharide derivative. Sisomicin has been used in trials studying the treatment of Pyoderma. Sisomicin is a broad-spectrum aminoglycoside antibiotic isolated from Micromonospora inyoensis. Sisomicin is strucurally similar to gentamicin but has a unique unsaturated diamino sugar. Of the aminoglycoside antibiotics, sisomicin has the greatest activity against gram-positive bacteria. It is grouped under the following drug class(es): Aminoglycosides. Its therapeutic use is listed as antibacterials and antibiotics. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Rickamicin, Sisomycin and Sissomicin. Its PubChem CID is 36119.

CAS No 32385-11-8
Molecular Formula C19H37N5O7
Molecular Weight 447.5 g/mol
Synonyms (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

Frequently Asked Questions